Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers
NCT01138371 is an observational study sponsored by Emory University. As of 21 Nov 2026, it is completed. It studies Familial Hypercholesterolemia. The registry lists an enrollment of 8 participants at 1 site in 1 country. The registry lists a start date of 31 Mar 2011 and a primary completion date of 29 Feb 2012.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01138371 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Emory University |
| Enrollment | 8 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Familial Hypercholesterolemia |
| Start | 31 Mar 2011 |
| Primary completion | 29 Feb 2012 |
| Study completion | 31 Mar 2012 |
| Last update posted | 17 Dec 2013 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Laurence Sperling, MD
Emory University
Principal Investigator - Vimal Ramjee, MD
Emory University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University Hospital
Atlanta
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01138371
Each answer restates registry values shown on this page.
What is NCT01138371?
NCT01138371 is an observational study sponsored by Emory University. It studies Familial Hypercholesterolemia.
Who leads NCT01138371?
The registry names Laurence Sperling, MD (principal investigator, Emory University) and Vimal Ramjee, MD (study director, Emory University) as overall officials.
Where does NCT01138371 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01138371 end?
The registry lists a primary completion date of 29 Feb 2012 and a study completion date of 31 Mar 2012. The sponsor last updated the record on 17 Dec 2013.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.